Trials / Completed
CompletedNCT01263834
Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome
The Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Prince of Songkla University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the adjunctive effect of intratenon Bevacizumab on the result of trabeculectomy in primary term of intraocular pressure (IOP).
Detailed description
Prospective interventional clinical trial Single center, outcome assessor-masked, active control, randomized controlled trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | Bevacizumab injection of 1.25m/0.05 cc + Mitomycin C soaked cellulose dose 0.4 mg/ml with 3 minutes of application |
| DRUG | Mitomycin C | Mitomycin C soaked cellulose dose 0.4 mg/ml with 3 minutes of application |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2010-12-21
- Last updated
- 2014-01-31
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01263834. Inclusion in this directory is not an endorsement.